Imuran 50 mg Tablet Филиппины - английский - FDA (Food And Drug Administration)

imuran 50 mg tablet

n/a; importer: aspen philippines inc.; distributor: n/a - azathioprine - tablet - 50 mg

Imuran 50mg Tablets Кения - английский - Pharmacy and Poisons Board

imuran 50mg tablets

beta healthcare international limited plot no. 209/6554, mogadishu road off lunga lunga - azathioprine - tablet - 50mg - other immunosuppressants

Imuran 25mg Намибия - английский - Namibia Medicines Regulatory Council

imuran 25mg

pharmacare limited - azathioprine 25 mg - tablet - 25mg azathioprine

Imuran Намибия - английский - Namibia Medicines Regulatory Council

imuran

pharmacare limited - azathioprine 50 mg - tablet - 50mg azathioprine

HUMIRA- adalimumab Соединенные Штаты - английский - NLM (National Library of Medicine)

humira- adalimumab

a-s medication solutions - adalimumab (unii: fys6t7f842) (adalimumab - unii:fys6t7f842) - humira is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. humira can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (dmards). humira is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. humira can be used alone or in combination with methotrexate. humira is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. humira can be used alone or in combination with non-biologic dmards. humira is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis. humira is indicated for reducing signs and symptoms and indu

HIGHLIGHTS OF PRESCRIBING INFORMATION Соединенные Штаты - английский - NLM (National Library of Medicine)

highlights of prescribing information

kadmon pharmaceuticals, llc - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin 200 mg - ribasphere® (ribavirin capsules usp) in combination with interferon alfa-2b (pegylated and nonpegylated) is indicated for the treatment of chronic hepatitis c (chc) in patients 3 years of age and older with compensated liver disease [see warnings and precautions (5.9, 5.10) , and use in specific populations (8.4) ]. the following points should be considered when initiating ribasphere combination therapy with peginterferon alfa-2b or interferon alfa-2b: ribasphere combination therapy is contraindicated in: teratogenic effects pregnancy category x [see contraindications (4), warnings and precautions (5.1), and nonclinical toxicology (13.1) ]. treatment and post-treatment: potential risk to the fetus: ribavirin is known to accumulate in intracellular components from where it is cleared very slowly. it is not known whether ribavirin contained in sperm will exert a potential teratogenic effect upon fertilization of the ova. in a study in rats, it was concluded that dominant lethality was not induced by ribavirin